Literature DB >> 2176870

Identification of essential tyrosine and lysine residues in angiotensin converting enzyme: evidence for a single active site.

Y N Chen1, J F Riordan.   

Abstract

Inactivation of rabbit lung angiotensin converting enzyme (ACE) by 1-fluoro-2,4-dinitrobenzene (Dnp-F) has been shown to be due primarily to the modification of a tyrosine residue [Bünning, P., Kleeman, S.G., & Riordan, J.F. (1990) Biochemistry (preceding paper in this issue)]. Rabbit testicular ACE is also inactivated by Dnp-F. The specific site of modification has been identified by peptide mapping of tryptic digests of the Dnp-modified protein. Two principal 340-nm-absorbing peaks, not observed with protein modified in the presence of inhibitor, have been characterized. Amino acid and sequence analyses show that these peptides contain two distinct residues that have been selectively modified. The sequence of the major (greater than 90% of the total) modified peptide is YVEFTNK with the Dnp group on tyrosine. The sequence of the second, minor peptide is KVQDLQR with the Dnp group on lysine. Identical peptides were obtained from Dnp-modified rabbit lung ACE. These modified amino acids correspond to residues 200 and 118, respectively, in testicular ACE (human enzyme numbering). Both peptides are present only in the carboxy-terminal half-domain of lung ACE, corresponding to residues 776 and 694, respectively. These results indicate that the Dnp-F sensitive, catalytically functional active site is located in the "testicular" half of lung ACE.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2176870     DOI: 10.1021/bi00498a011

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  5 in total

1.  Use of alternative polyadenylation sites for tissue-specific transcription of two angiotensin-converting enzyme mRNAs.

Authors:  T J Thekkumkara; W Livingston; R S Kumar; G C Sen
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

2.  RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites.

Authors:  V Dive; J Cotton; A Yiotakis; A Michaud; S Vassiliou; J Jiracek; G Vazeux; M T Chauvet; P Cuniasse; P Corvol
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

3.  A comparison of the zinc contents and substrate specificities of the endothelial and testicular forms of porcine angiotensin converting enzyme and the preparation of isoenzyme-specific antisera.

Authors:  T A Williams; K Barnes; A J Kenny; A J Turner; N M Hooper
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

4.  Angiotensin-converting enzyme of the human small intestine. Subunit and quaternary structure, biosynthesis and membrane association.

Authors:  H Y Naim
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

5.  Molecular and thermodynamic mechanisms of the chloride-dependent human angiotensin-I-converting enzyme (ACE).

Authors:  Christopher J Yates; Geoffrey Masuyer; Sylva L U Schwager; Mohd Akif; Edward D Sturrock; K Ravi Acharya
Journal:  J Biol Chem       Date:  2013-12-02       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.